Board of Directors
President
- George Nakayama
- Representative Director,Chairman and CEO
- Daiichi Sankyo Co., Ltd.
Vice President
- Haruo Naito
- Representative Corporate Officer and CEO
- Eisai Co., Ltd.
- Yoshihiko
Hatanaka
- Representative Director,Chairman
- Astellas Pharma Inc.
- Isao Teshirogi,Ph.D.
- President and Representative Director
- Shionogi & Co., Ltd.
- Masayo Tada
- Representative Director,Chairman
- Sumitomo Dainippon Pharma Co., Ltd
- Masato Iwasaki,Ph.D.
- President,Japan Pharma Business Unit
- Takeda Pharmaceutical Co., Ltd.
- Masayuki Mitsuka
- President & Representative Director Chief Executive Officer
- Mitsubishi Tanabe Pharma Co., Ltd.
Standing Director
- Stefan Woxström
- Representative Director and President
- AstraZeneca K.K.
- Osamu Nagayama
- Chairman & CEO
- Chugai Pharmaceutical Co., Ltd.
- Philippe Fauchet
- Chairman,Representative Director
- GlaxoSmithKline K.K.
- Mutsuo Kanzawa
- Chaiman and CEO
- Kissei Pharmaceutical Co., Ltd.
- Nobuo Hanai, Ph.D.
- Executive Director,Chairman and CEO
- Kyowa Hakko Kirin Co., Ltd.
- Jannie Oosthuizen
- Representative Director and President
- MSD Co., Ltd.
- Nobuyuki Morishima
- Vice President and Representative Director
- Otsuka Pharmaceutical Co., Ltd.
- Akihisa Harada,
Ph.D.
- President & Representative Director
- Pfizer Japan Inc.
- Jacques Nathan
- President and Representative Director
- Sanofi K.K
Directors
- Yoshikazu Aoki, Ph.D.
- President & CEO
- Asahi kasei Pharma Corporation
- Heike Prinz
- President
- Bayer Yakuhin, Ltd.
- Jean-Christophe Barland
- Representative Director and President
- Bristol-Myers Squibb K.K.
- Patrik Jonsson
- President and General Manager
- Eli Lilly Japan K.K.
- Hirotaka Nakatomi
- Chairman & CEO
- Hisamitsu Pharmaceutical Co., Inc
- Chris Hourigan
- President
- Janssen Pharmaceutical K.K.
- Tetsuo Onuma
- President and Representative Director
- Kaken Pharmaceutical Co., Ltd
- Yoshihiro Miwa
- President and CEO
- Kowa Co., Ltd.
- Minoru Hogawa
- Representative Director
President and Chief Executive Officer
- Kyorin Pharmaceutical Co., Ltd.
- Daikichiro Kobayashi
- President and Representative Director
- Meiji Seika Pharma Co., Ltd.
- Naoyuki Mochida
- President
- Mochida Pharmaceutical Co., Ltd.
- Yoshiaki Aono
- Representative Director and President
- Nippon Boehringer Ingelheim Co., Ltd.
- Shigenobu Maekawa
- President
- Nippon Shinyaku Co., Ltd.
- Gyo Sagara
- President and Representative Director Chief Executive Officer
- Ono Pharmaceutical Co., Ltd.
- Akira Kurokawa
- President and CEO
- Santen Pharmaceutical Co., Ltd.
- Masayuki Kobayashi
- President
- Taiho Pharmaceutical Co., Ltd.
- Akihisa Nabeshima
- President
- Teijin Pharma Limited
- Shigeru Uehara
- Chief Executive Officer
- Taisho Pharmaceutical Co., Ltd.
- Shoichiro Takagi
- Representative Director, President and CEO
- Torii Pharmaceutical Co., Ltd.
Auditors
- Takashi Yamaguchi, Ph.D.
- President & Representative Director
- ASKA Pharmaceutical Co., Ltd.
- Sachiaki Ibe
- Chairman & CEO
- Zeria Pharmaceutical Co., Ltd.
Secretariat
- Tadaharu Goto
- Director General
- Akira Kawahara
- Senior Managing Director
- Tokuo Tanaka
- Managing Director
- Akihiko Matsubara
- Managing Director
Page Top
